Evolution of Zika prevalence in a dengue hyperendemic municipality in Southern Mexico after the outbreak of 2015 to 2017
Salud Pública de México · 2024
DOI: 10.21149/15407 ↗At a glance
Journal article in Salud Pública de México, 2024. Written by Carlos Gaspar-Castillo and 12 co-authors. Institution: Centro de Investigación Sobre Enfermedades Infecciosas, Instituto Nacional de Salud Pública. Cuernavaca, Morelos, Mexico.. eduardo.gaspar@insp.edu.mx. Major MEDLINE topics: Zika Virus Infection, Dengue, Disease Outbreaks, Endemic Diseases. Cited 1 times so far (Crossref). The full text is freely available (open access, CC BY-NC-SA 4.0).
Abstract (original language)
Objective
Estimate the Zika prevalence in a dengueendemic municipality in Mexico, after the outbreak of 2015 to 2017. Materials and methods. Three serosurveys were conducted in Tapachula, Chiapas, in September 2018, March 2019 and November 2019. A commercial ZIKV and DENV anti-NS1 IgG ELISA were used to estimate each prevalence, their performance and adjustment of the cut-off value were compared with an in-house DENVs and ZIKV anti-EDIII IgG ELISA and the microneutralization test.
Results
The anti-NS1 ZIKV titers decreased over time, causing that Zika prevalence decreased from 78.02 to 45.22%, while anti-NS1 DENV titers increased, and the prevalence remained above 95% over a two-year period.
Conclusion
Optimal Zikaprevalence estimates can be obtained in a two-years period after outbreaks in dengue-endemic areas. The extension of the Zika outbreak is significantly higher than previously reported in Tapachula, highlighting the underreport of cases based on the routine flavivirus surveillance system in Mexico.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Centro de Investigación Sobre Enfermedades Infecciosas, Instituto Nacional de Salud Pública. Cuernavaca, Morelos, Mexico.. eduardo.gaspar@insp.edu.mx.
- Subsecretaría de Prevención y Promoción de la Salud, Secretaría de Salud. Mexico City, Mexico.. anais.cortes@salud.gob.mx.
- Departamento de Virología, Instituto de Diagnóstico y Referencia Epidemiológicos. Mexico City, Mexico.. rodrigo.aparicio@salud.gob.mx.
- Centro de Investigación en Salud Poblacional, Instituto Nacional de Salud Pública. Cuernavaca, Morelos, Mexico.. mcarnalla@gmail.com.
- Departamento de Génetica del Desarrollo y Fisiología Molecular, Instituto de Biotecnología, Universidad Nacional Autónoma de México. Cuernavaca, Morelos, Mexico.. susana.lopez@ibt.unam.mx.
- VIR Biotechnology Inc. San Francisco, CA, USA.. liliana.sanchez.tacuba@gmail.com.
Cite
APA
Gaspar-Castillo, C., Cortes-Escamilla, A., Aparicio-Antonio, R., Carnalla, M., López, S., Sánchez-Tacuba, L., Oceguera-Cabrera, A., Burrone, Ó., González-Bonilla, C., Ortiz Navarrete, V., Martínez-Barnetche, J., Rodríguez, M. H., & Alpuche-Aranda, C. M. (2024). Evolution of Zika prevalence in a dengue hyperendemic municipality in Southern Mexico after the outbreak of 2015 to 2017. Salud Pública de México. https://doi.org/10.21149/15407
Vancouver
Gaspar-Castillo C, Cortes-Escamilla A, Aparicio-Antonio R, Carnalla M, López S, Sánchez-Tacuba L, et al. Evolution of Zika prevalence in a dengue hyperendemic municipality in Southern Mexico after the outbreak of 2015 to 2017. Salud Pública de México. 2024. doi:10.21149/15407
BibTeX
@article{GasparCastillo2024,
author = {Gaspar-Castillo, Carlos and Cortes-Escamilla, Anais and Aparicio-Antonio, Rodrigo and Carnalla, Martha and López, Susana and Sánchez-Tacuba, Liliana and Oceguera-Cabrera, Alfonso and Burrone, Óscar and González-Bonilla, César and Ortiz Navarrete, Vianney and Martínez-Barnetche, Jesus and Rodríguez, Mario Henry and Alpuche-Aranda, Celia M},
title = {Evolution of Zika prevalence in a dengue hyperendemic municipality in Southern Mexico after the outbreak of 2015 to 2017},
journal = {Salud Pública de México},
year = {2024},
doi = {10.21149/15407}
}
EUVIMED